Psychotropic Drug Utilization Pattern among Schizophrenics by Dutta, Shakti Bala et al.
381
Psychotropic Drug Utilization Pattern among Schizophrenics
Shakti Bala Dutta*1, D.C. Dhasmana2, Reena Bhardwaj3
LETTER TO THE EDITOR Indian Journal of Psychiatry, 2004, 46(4)381
Sir,
Schizophrenia is a chronic debilitating major psychiatric
disorder which may require life long treatment. Treatment
of such patients at an early stage may prevent loss of
morbidity, mortality and productivity. Till date,
pharmacotherapy remains the cornerstone of treatment in
such patients . Serendipitous discovery of chlorpromazine
and lithium in the fifties brought about a revolution in the
field of psychopharmacology. Although highly efficacious,
the side-effects (Kane, 1987) produced by these older
conventional drugs were distressing leading to an active
search for better agents. Advent of newer antipsychotic
agents like olanzapine , risperidone and quetiapine has led
to major changes in drug usage pattern in psychiatry,besides
other considerations related to disease,patients,drugs and
physician.
With a variety of antipsychotic agents that are presently
available, it is difficult at times to select a particular
antipsychotic drug on rational basis alone but on empiricism.
They are increasingly used for a variety of indications at
present. Keeping these factors in mind, a prospective study
was conducted by Department of Pharmacology in
Psychiatry OPD of Himalayan Institute Hospital, a tertiary
care teaching hospital in Uttaranchal during the year 2002-
2003. The aim of the study was to analyze the prescribing
pattern of drugs in chronic stable schizophrenic patients
and to correlate the availability of newer medicines in the
market and its usage or impact on psychiatric practice in
the present scenario. One hundred and eighteen adult stable
schizophrenic patients diagnosed according to the DSM-
IV criteria (APA, 1994) were included in the study.
Individual data was collected in a preformed format and
was analysed on parameters such as distribution of subsets
of  disease, demographic profile and psychotropic drug use
pattern.
Results showed the distribution of different types of
schizophrenics: paranoid schizophrenia 1.7% (61),
disorganized schizophrenia 9% (7),catatonic schizophrenia
10.2% (12),undifferentiated 3.4% (4) and residual 11.8%
(14) episodic i.e.interepisodic residual symptoms with
prominent negative symptoms10.1%(12) and episodic with
no interepisodic symptoms or continuous with prominent
negative symptoms 6.7% (8). As per the demographic
profile, the number of patients below 30 years were 68
(57.62%) and above 30 years 50 (42.37%), number of males
were 64 (54.23%) and females 54 (45.76%). Socio-
economically, the number of patients in upper income group
were 45, middle income group were 62 and 11 patients
belonged to the low socioeconomic status. Of the118
schizophrenic patients, 28 were professionals and 51 non-
professionals ,whereas students were 23 and labourers or
farmers constituted 16 .There were 84 (71.19%) hindus,18
(15.25%) muslims,12(10.16%) sikhs and 4 (3.38%)
belonged to other categories.
Table 1
DRUG USE PATTERN OF SCHIZOPHRENIC
PATIENTS IN PSYCHIATRY OPD
1. Total number of prescriptions (n) = 118
2. Total number of drugs used = 338
3. Average number of drugs per
prescription = 2.8
4. Number of fixed dose combinations =  8
5. Types of Psychotropic drugs used:
a. Antipsychotics = 189(55.9%)
b.  Antidepressants =   23 (6.8%)
c. Antimanics =   12 (3.5%)
d. Anxiolytics =   18 (5.3%)
e. Anticholinergics =   64(18.9%)
f.  Miscellaneous =   32 (9.4%)
A total of 338 drugs were prescribed , out of which 316
were used orally and 22 given parenterally as depot
formulations. Different antipsychotics used comprised of
olanzapine 44.4%,haloperidol 28.5%,risperidone
9.5%,quetiapine 6.3%,aripiprazole 5.2%,ziprasidone 4.2%
and thioridazine 2.6%.Out of 189 orally used antipsychotic
medications,only one antipsychotic drug was prescribed to
58 patients, two  to 49 patients and more than two to 11
patients. Among anticholinergics, trihexyphenidyl was
prescribed to 64 schizophrenic patients,antidepressants to
23 patients, anxiolytics to 18 and   anti- manic or mood
stabilizer to 12 patients. Most commonly prescribed
antipsychotic was olanzapine followed by haloperidol and
risperidone.
A multi - drug therapy trend was observed. A shift towards
the use of newer atypical antipsychotic agents was evident.
Concomitent anticholinergics were used only in about half
of the patients reflecting its reduced usage with increasing
use of newer atypical antipsychotics. Fixed dose382
combinations were also prescribed occasionally. Other
psychotropic medications prescribed as adjunctive treatment
were antidepressants i.e. venlafaxine and fluoxetine,
anxiolytics i.e. clonazepam and sodium valproate as
antimanic agent.
The treatment pattern observed correlates with the
worldwide changing trends in the treatment of
schizophrenia. In recent years, the introduction of newer
atypical antipsychotic agents like olanzapine, risperidone,
quetiapine and ziprasidone have provided a better control
of  symptoms and reduced adverse effects especially the
extrapyramidal ones in contrast with older drugs. The newer
atypical antipsychotics also proved to be better in improving
of negative symptoms,cognitive dysfunction and may also
be efficacious in neuroleptic-resistant schizophrenia (Robert
Freedman, 2003 ; Serretti et al., 2004). With the recent
introduction of yet another newer third generation
antipsychotic agent aripiprazole with serotonin-dopamine
system stabilising action, further improvement in the
management of  schizophrenic patients is envisaged with
bright future.
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Management of unexplained somatic symptoms in
general and dental hospital settings
Sir,
We read with interest the article on somatic symptoms and
psychiatric disorders by Gada and Shah (2004). Psychiatrists
differentiate the various clinical presentations into specific
diagnostic categories such as somatization, neurasthenia,
depression, generalised anxiety, panic, phobia, adjustment
disorders, etc. The recognition of the different syndromes
and the implementation of specific management strategies
are complex processes.
Patients with distressing physical symptoms, without known
medical causes, also frequently present to physicians
working in general medical and dental hospitals. However,
these patients usually have milder and less complex forms
of psychiatric disorder, which are difficult to differentiate
into the classical psychiatric syndromes as these individuals
often have mixed presentations. In addition, the reality of
general hospitals requires management strategies, which
are simple and brief. Consequently, a completely different
approach is required to manage such patients. Doctors who
deal with such patients in busy medical, surgical or dental
practices need to be provided with an alternative approach
that consists of a simple model of management that is
practical and appropriate for their setting. Training
programmes in psychiatry for medical students, physicians
and dentists should emphasize such an approach, which
will empower physicians in general practice, to manage
these frequently encountered psychiatric problems.
A simple protocol to manage unexplained somatic
complaints in medical and dental practice (Jacob, 2004)
has been successfully employed in primary care and taught
to physicians, medical students and psychiatrists at the
Christian Medical College, Vellore, India, for the past 6
years. It is based on the reattribution model” and on available
literature on the subject (Fink, 2000; Mayou & Farmer, 2002;
Bass & May 2002). The steps are briefly described. The
major tasks include: (i) Building a therapeutic relationship
(ii) Providing reassurance and alternative explanations for
symptoms (iii) Suggesting therapeutic options (iv) Offering
continued support. These tasks can be broken down into
10 simple steps:
Step I: Acknowledge distress caused by symptoms- this
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